Darling Ingredients' Rousselot has announced receipt of US patent for StabiCaps gelatin technology
Rousselot, a health brand of Darling Ingredients, has been granted a U.S. Patent and Trademark Office Patent No. UA11795489B2 for its StabiCaps product.
Photo © Shutterstock.com/jovan vitanovski
Rousselot, a health brand of Darling Ingredients (Irving, CA), has been granted a U.S. Patent and Trademark Office Patent No. UA11795489B2, securing the intellectual property rights for StabiCaps, which is a specialized gelatin that improves the formulation and stability of soft gel capsules by addressing crosslinking. The company explains in a press release that crosslinking happens when the soft gels are exposed to specific active compounds or poor storage conditions to cause molecular bonds within the capsule shell that limit or prevent dissolution of the capsule.
“StabiCaps is an essential innovation for soft gel manufacturers because gelatin is a primary ingredient,” said Pierre-Albert Thomas, Rousselot Functional Ingredients Director, in a press release. “With this new patent, soft gel manufacturers in the U.S. can unlock the benefits of StabiCaps gelatin technology to produce high-quality soft gels with longer shelf stability and improved efficacy for customers.”
Kaneka Nutrients to unveil new consumer research on menopausal women at Vitafoods Europe 2024
April 26th 2024The company will reveal the results of the research that is based on live feedback from 200 menopausal women who took 200 mg per day of Kaneka Ubiquinol over two-months, monitored the effects, and recorded their observations.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
